Skip to content

Efficacy and Safety of Calcium Polycarbophil Tablets Combined with Polyethylene Glycol Electrolyte Solution for Bowel Preparation in Elderly Patients with Chronic Constipation: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial

Efficacy and Safety of Calcium Polycarbophil Tablets Combined with Polyethylene Glycol Electrolyte Solution for Bowel Preparation in Elderly Patients with Chronic Constipation: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118784
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation for Colonoscopy in Elderly Patients with Chronic Constipation

Interventions

Group A:Calcium Polycarbophil Tablets+ Polyethylene Glycol (PEG)
Group B:Polyethylene Glycol (PEG)

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years, any gender, scheduled for elective colonoscopy; 2. Diagnosis of chronic constipation; 3. Voluntary participation in the study, signed informed consent, and good compliance.

Exclusion criteria

Exclusion criteria: 1. Individuals with contraindications to bowel preparation or colonoscopy; 2. Recent (within 7 days before enrollment) use of medications that may interact with the study drugs, including active vitamin D preparations, calcium supplements, tetracyclines and quinolone antibiotics, proton pump inhibitors, H2 receptor antagonists, or antacids, or use of laxatives (e.g., lactulose, PEG, mannitol, senna, etc.); 3. Presence of colorectal cancer alarm symptoms or signs, such as hematochezia, melena, unexplained anemia or weight loss, abdominal mass, or positive findings on digital rectal examination; 4. Presence of intestinal obstruction, intestinal perforation, acute abdominal pain, or suspected acute abdomen; 5. History of gastrointestinal surgery resulting in significant anatomical alterations (e.g., extensive bowel resection, ostomy, gastrointestinal bypass surgery); 6. Active inflammatory bowel disease, such as ulcerative colitis or Crohn’s disease; 7. Severe dysphagia or gastrointestinal strictures; 8. Severe cardiopulmonary, hepatic, or renal dysfunction, making colonoscopy unsuitable; 9. Electrolyte disturbances; 10. Known allergy or intolerance to calcium polycarbophil, polyethylene glycol electrolyte solution, or any excipients used in this study; 11. Hypercalcemia or a history of conditions predisposing to hypercalcemia; 12. History of kidney stones; 13. Significant cognitive impairment, severe dementia, or psychiatric disorders preventing participation in the study.

Design outcomes

Primary

MeasureTime frame
Boston Bowel Preparation Scale;

Secondary

MeasureTime frame
Bowel preparation completion rate;Cleansing score of each colonic segment;Bubble score;Adenoma Detection Rate;Polyp Detection Rate;Gut microbiota indicators;Willingness to repeat colonoscopy;Willingness to repeat the bowel preparation;Tolerance rate of bowel preparation;Adverse Events;

Countries

China

Contacts

Public ContactDekui Zhang

Lanzhou University Second Hospital

sczdk1972@163.com+86 139 0931 8616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026